Figure 1. Research Method Flow Chart 14
Figure 2. Breakdown of Primary Research 16
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 20
Figure 5. Global Oral Antibiotics Market, 2019-2030, $ mn 23
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of Global Oral Antibiotics Market 26
Figure 8. GDP per capita in the World, 1960-2018, $ thousand 29
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 29
Figure 10. Primary Restraints and Impact Factors of Global Oral Antibiotics Market 30
Figure 11. Investment Opportunity Analysis 34
Figure 12. Porter’s Fiver Forces Analysis of Global Oral Antibiotics Market 37
Figure 13. Breakdown of Global Oral Antibiotics Market by Drug Class, 2019-2030, % of Revenue 42
Figure 14. Global Addressable Market Cap in 2020-2030 by Drug Class, Value ($ mn) and Share (%) 42
Figure 15. Global Oral Antibiotics Market: Cephalosporin, 2019-2030, $ mn 43
Figure 16. Global Oral Antibiotics Market: Penicillin, 2019-2030, $ mn 45
Figure 17. Global Oral Antibiotics Market: Macrolides, 2019-2030, $ mn 46
Figure 18. Global Oral Antibiotics Market: Tetracycline, 2019-2030, $ mn 47
Figure 19. Global Oral Antibiotics Market: Quinolones, 2019-2030, $ mn 48
Figure 20. Global Oral Antibiotics Market: Sulfonamides, 2019-2030, $ mn 49
Figure 21. Global Oral Antibiotics Market: Aminoglycosides, 2019-2030, $ mn 50
Figure 22. Global Oral Antibiotics Market: Other Drug Classes, 2019-2030, $ mn 51
Figure 23. Breakdown of Global Oral Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue 53
Figure 24. Global Addressable Market Cap in 2020-2030 by Action Mechanism, Value ($ mn) and Share (%) 53
Figure 25. Global Oral Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, $ mn 54
Figure 26. Global Oral Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, $ mn 55
Figure 27. Global Oral Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, $ mn 56
Figure 28. Global Oral Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, $ mn 57
Figure 29. Global Oral Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, $ mn 58
Figure 30. Global Oral Antibiotics Market: Other Mechanisms, 2019-2030, $ mn 59
Figure 31. Breakdown of Global Oral Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue 61
Figure 32. Global Addressable Market Cap in 2020-2030 by Drug Origin, Value ($ mn) and Share (%) 61
Figure 33. Global Oral Antibiotics Market: Natural Antibiotics, 2019-2030, $ mn 62
Figure 34. Global Oral Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, $ mn 63
Figure 35. Global Oral Antibiotics Market: Synthetic Antibiotics, 2019-2030, $ mn 64
Figure 36. Breakdown of Global Oral Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue 66
Figure 37. Global Addressable Market Cap in 2020-2030 by Activity Spectrum, Value ($ mn) and Share (%) 66
Figure 38. Global Oral Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, $ mn 67
Figure 39. Global Oral Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, $ mn 68
Figure 40. Breakdown of Global Oral Antibiotics Market by Application, 2019-2030, % of Revenue 70
Figure 41. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 70
Figure 42. Global Oral Antibiotics Market: Urinary Tract Infections (UTIS), 2019-2030, $ mn 71
Figure 43. Global Oral Antibiotics Market: Dental Infections, 2019-2030, $ mn 72
Figure 44. Global Oral Antibiotics Market: Monotherapies for Dental Infections, 2019-2030, $ mn 73
Figure 45. Global Oral Antibiotics Market: Combined Therapies for Dental Infections, 2019-2030, $ mn 74
Figure 46. Global Oral Antibiotics Market: Respiratory Tract Infections (RTIS), 2019-2030, $ mn 75
Figure 47. Global Oral Antibiotics Market: Upper Respiratory Tract Infections (URTI), 2019-2030, $ mn 76
Figure 48. Global Oral Antibiotics Market: Lower Respiratory Tract Infections (LRTIs), 2019-2030, $ mn 77
Figure 49. Global Oral Antibiotics Market: Other Applications, 2019-2030, $ mn 78
Figure 50. Breakdown of Global Oral Antibiotics Market by Drug Type, 2019-2030, % of Revenue 79
Figure 51. Global Addressable Market Cap in 2020-2030 by Drug Type, Value ($ bn) and Share (%) 80
Figure 52. Global Oral Antibiotics Market: Brand Antibiotics, 2019-2030, $ bn 81
Figure 53. Global Oral Antibiotics Market: Generic Antibiotics, 2019-2030, $ bn 82
Figure 54. Global Market Snapshot by Region 83
Figure 55. Geographic Spread of Worldwide Oral Antibiotics Market, 2019-2030, % of Sales Revenue 84
Figure 56. Global Addressable Market Cap in 2020-2030 by Region, Value ($ bn) and Share (%) 85
Figure 57. Health Spending as a Share of GDP by Country, 2015 and 2030 87
Figure 58. North American Oral Antibiotics Market, 2019-2030, $ bn 90
Figure 59. Breakdown of North America Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 91
Figure 60. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 92
Figure 61. U.S. Oral Antibiotics Market, 2019-2030, $ bn 94
Figure 62. Rising Incidence of Infectious Disease in U.S. 94
Figure 63. Canada Oral Antibiotics Market, 2019-2030, $ bn 97
Figure 64. Oral Antibiotics Market in Mexico, 2015-2030, $ bn 99
Figure 65. European Oral Antibiotics Market, 2019-2030, $ bn 102
Figure 66. Breakdown of European Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 103
Figure 67. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 104
Figure 68. Oral Antibiotics Market in Germany, 2019-2030, $ bn 105
Figure 69. Oral Antibiotics Market in UK, 2019-2030, $ bn 107
Figure 70. Oral Antibiotics Market in France, 2019-2030, $ bn 109
Figure 71. Oral Antibiotics Market in Spain, 2019-2030, $ bn 111
Figure 72. Oral Antibiotics Market in Italy, 2019-2030, $ bn 113
Figure 73. Oral Antibiotics Market in Russia, 2019-2030, $ bn 115
Figure 74. Oral Antibiotics Market in Rest of Europe, 2019-2030, $ bn 117
Figure 75. Asia-Pacific Oral Antibiotics Market, 2019-2030, $ bn 120
Figure 76. Breakdown of APAC Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 120
Figure 77. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 122
Figure 78. Oral Antibiotics Market in Japan, 2019-2030, $ bn 124
Figure 79. Oral Antibiotics Market in China, 2019-2030, $ bn 126
Figure 80. Oral Antibiotics Market in Australia, 2019-2030, $ bn 128
Figure 81. Oral Antibiotics Market in India, 2019-2030, $ bn 130
Figure 82. Oral Antibiotics Market in South Korea, 2019-2030, $ bn 132
Figure 83. Oral Antibiotics Market in Rest of APAC, 2019-2030, $ bn 134
Figure 84. South America Oral Antibiotics Market, 2019-2030, $ bn 137
Figure 85. Breakdown of South America Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 137
Figure 86. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 138
Figure 87. Oral Antibiotics Market in Argentina, 2019-2030, $ bn 139
Figure 88. Oral Antibiotics Market in Brazil, 2019-2030, $ bn 141
Figure 89. Oral Antibiotics Market in Chile, 2019-2030, $ bn 143
Figure 90. Oral Antibiotics Market in Rest of South America, 2019-2030, $ bn 145
Figure 91. Oral Antibiotics Market in Middle East and Africa (MEA), 2019-2030, $ bn 147
Figure 92. Breakdown of MEA Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 147
Figure 93. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 148
Figure 94. Oral Antibiotics Market in UAE, 2019-2030, $ bn 149
Figure 95. Oral Antibiotics Market in Saudi Arabia, 2019-2030, $ bn 151
Figure 96. Oral Antibiotics Market in South Africa, 2019-2030, $ bn 153
Figure 97. Growth Stage of Global Oral Antibiotics Industry over the Forecast Period 156
Global oral antibiotics market will reach $26.67 billion by 2030, growing by 4.0% annually over 2020-2030 driven by rising complications associated with COVID-19 epidemic, development of innovative antibiotics, and growing healthcare expenditure. Highlighted with 89 tables and 97 figures, this 187-page report “Global Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global oral antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global oral antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region. Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Cephalosporin • Cefuroxime Axetil • Cephalexin • Cefixime • Cefpodoxime • Other Cephalosporin Penicillin Macrolides Tetracycline Quinolones Sulfonamides Aminoglycosides Other Drug Classes Based on Action Mechanism, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Cell Wall Synthesis Inhibitors • Mycolic Acid Inhibitors • RNA Synthesis Inhibitors • DNA Synthesis Inhibitors • Protein Synthesis Inhibitors • Other Mechanisms Based on Drug Origin, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Natural Antibiotics • Semi-synthetic Antibiotics • Synthetic Antibiotics Based on Activity Spectrum, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Broad-spectrum Antibiotics • Narrow-spectrum Antibiotics Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Urinary Tract Infections (UTIS) • Upper Respiratory Tract Infections (URTI) • Lower Respiratory Tract Infections (LRTIs) Dental Infections • Monotherapies • Combined Therapies Respiratory Tract Infections (RTIS) Other Applications Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Brand Antibiotics • Generic Antibiotics Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • RoW (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Class, Drug Origin, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global oral antibiotics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories Astellas Pharma AstraZeneca Plc Bayer AG Bristol Myers Squibb Company Cipla Inc. Dr. Reddy’s Laboratories Ltd. Eli Lilly and Company F. Hoffmann-La Roche Ltd. Gilead Sciences, Inc. GlaxoSmithKline plc. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) Mayne Pharma Group Ltd. MELINTA THERAPEUTICS, INC. Merck KGaA Novartis AG Pfizer Inc. Sanofi Sun Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More